Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Alzheimer's Disease

Free Subscription 03.10.2022 6 Alzheimers Dement 1 Ann Neurol 2 Biochemistry (Mosc) 1 Biol Psychiatry 1 BMC Geriatr 3 Exp Gerontol 1 Int J Neurosci 12 J Alzheimers Dis 3 J Neurochem 1 Nat Med 1 Nat Neurosci 1 Nature 1 Neurobiol Aging 2 Neurobiol Dis 1 Neurology 1 Neurosci Lett 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. HARTZ SM, Mozersky J, Schindler SE, Linnenbringer E, et al
   A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.
   Alzheimers Dement. 2022 Sep 30. doi: 10.1002/alz.12781.
   PubMed         Abstract available
   
   
2. PICHET BINETTE A, Janelidze S, Cullen N, Dage JL, et al
   Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
   Alzheimers Dement. 2022 Sep 24. doi: 10.1002/alz.12787.
   PubMed         Abstract available
   
   
3. LIU KY, Thambisetty M, Howard R
   How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?
   Alzheimers Dement. 2022 Sep 26. doi: 10.1002/alz.12788.
   PubMed         Abstract available
   
   
4. WEAVER DF
   Alzheimer's disease as an innate autoimmune disease (AD(2) ): A new molecular paradigm.
   Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12789.
   PubMed         Abstract available
   
   
5. KATABATHULA S, Davis PB, Xu R
   Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of Alzheimer's disease.
   Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12792.
   PubMed         Abstract available
   
   
6. SCHAEVERBEKE J, Tome SO, Ronisz A, Ospitalieri S, et al
   Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes.
   Alzheimers Dement. 2022 Sep 28. doi: 10.1002/alz.12794.
   PubMed         Abstract available
   
   

   
   Ann Neurol

7. JOSEPH-MATHURIN N, Llibre-Guerra JJ, Li Y, McCullough AA, et al
   Amyloid-related imaging abnormalities in the DIAN-TU-001 trial of gantenerumab and solanezumab: lessons from a trial in dominantly inherited Alzheimer disease.
   Ann Neurol. 2022 Sep 24. doi: 10.1002/ana.26511.
   PubMed         Abstract available
   
   

   
   Biochemistry (Mosc)

8. ZAKHAROVA NV, Bugrova AE, Indeykina MI, Fedorova YB, et al
   Proteomic Markers and Early Prediction of Alzheimer's Disease.
   Biochemistry (Mosc). 2022;87:762-776.
   PubMed         Abstract available
   
   
9. EPREMYAN KK, Goleva TN, Zvyagilskaya RA
   Effect of Tau Protein on Mitochondrial Functions.
   Biochemistry (Mosc). 2022;87:689-701.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

10. KIM JP, Kim BH, Bice PJ, Seo SW, et al
    Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer's Disease.
    Biol Psychiatry. 2022 Jun 24. pii: S0006-3223(22)01369.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

11. VAZQUEZ-JUSTES D, Aguirregoicoa I, Fernandez L, Carnes-Vendrell A, et al
    Clinical impact of microbleeds in patients with Alzheimer's disease.
    BMC Geriatr. 2022;22:774.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

12. ABUELEZZ NZ, Nasr FE, Abdel Aal WM, Molokhia T, et al
    Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population.
    Exp Gerontol. 2022;169:111961.
    PubMed         Abstract available
    
    
13. HE X, Yan C, Zhao S, Zhao Y, et al
    The preventive effects of probiotic Akkermansia muciniphila on D-galactose/AlCl3 mediated Alzheimer's disease-like rats.
    Exp Gerontol. 2022 Sep 21:111959. doi: 10.1016/j.exger.2022.111959.
    PubMed         Abstract available
    
    
14. SAYEHMIRI F, Khodagholi F, Pourbadie HG, Naderi N, et al
    Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats.
    Exp Gerontol. 2022;168:111944.
    PubMed         Abstract available
    
    

    
    Int J Neurosci

15. MANDLIK DS, Mandlik SK, S Arulmozhi
    Therapeutic Implications of Glycogen Synthase Kinase-3beta in Alzheimer's disease: A Novel Therapeutic Target.
    Int J Neurosci. 2022 Sep 30:1-27. doi: 10.1080/00207454.2022.2130297.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

16. MORROW A, Panyard DJ, Deming YK, Jonaitis E, et al
    Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220349. doi: 10.3233/JAD-220349.
    PubMed         Abstract available
    
    
17. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220359. doi: 10.3233/JAD-220359.
    PubMed         Abstract available
    
    
18. DENTONI G, Naia L, Portal B, Leal NS, et al
    Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220383. doi: 10.3233/JAD-220383.
    PubMed         Abstract available
    
    
19. ZARBOCK KR, Han JH, Singh AP, Thomas SP, et al
    Trimethylamine N-Oxide Reduces Neurite Density and Plaque Intensity in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220413. doi: 10.3233/JAD-220413.
    PubMed         Abstract available
    
    
20. YAMADA Y, Kobayashi M, Shinkawa K, Nemoto M, et al
    Characteristics of Drawing Process Differentiate Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Sep 20. pii: JAD220546. doi: 10.3233/JAD-220546.
    PubMed         Abstract available
    
    
21. ALVAREZ XA, Winston CN, Barlow JW, Sarsoza FM, et al
    Modulation of Amyloid-beta and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin(R) and Donepezil.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220575. doi: 10.3233/JAD-220575.
    PubMed         Abstract available
    
    
22. TRUMBORE CN, Raghunandan A
    An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220622. doi: 10.3233/JAD-220622.
    PubMed         Abstract available
    
    
23. DOWNEY J, Lam JCK, Li VOK, Gozes I, et al
    Somatic Mutations and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220643. doi: 10.3233/JAD-220643.
    PubMed         Abstract available
    
    
24. KHEZRI MR, Esmaeili A, Ghasemnejad-Berenji M
    Platelet Activation and Alzheimer's Disease: The Probable Role of PI3K/AKT Pathway.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220663. doi: 10.3233/JAD-220663.
    PubMed         Abstract available
    
    
25. XU C, Zhao L, Dong C
    A Review of Application of Abeta42/40 Ratio in Diagnosis and Prognosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220673. doi: 10.3233/JAD-220673.
    PubMed         Abstract available
    
    
26. VILLAREJO-GALENDE A, Garcia-Arcelay E, Pinol-Ripoll G, Del Olmo-Rodriguez A, et al
    Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 23. pii: JAD220696. doi: 10.3233/JAD-220696.
    PubMed         Abstract available
    
    
27. SABBIR MG, Speth RC, Albensi BC
    Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220766. doi: 10.3233/JAD-220766.
    PubMed         Abstract available
    
    

    
    J Neurochem

28. VAZ M, Martins TS, Henriques AG
    Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: methodologies applied from cells to biofluids.
    J Neurochem. 2022 Sep 26. doi: 10.1111/jnc.15697.
    PubMed         Abstract available
    
    
29. DUARTE JMN
    Serine racemase modulation for improving brain insulin resistance: An Editorial Highlight for "Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-beta oligomers": An Editorial Highlight for "Deletion of serine racema
    J Neurochem. 2022;163:6-7.
    PubMed         Abstract available
    
    
30. ZHOU J, Zhang Z, Yang Y, Liao F, et al
    Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid-beta oligomers.
    J Neurochem. 2022;163:8-25.
    PubMed         Abstract available
    
    

    
    Nat Med

31. JUNG H, Lee SY, Lim S, Choi HR, et al
    Anti-inflammatory clearance of amyloid-beta by a chimeric Gas6 fusion protein.
    Nat Med. 2022;28:1802-1812.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

32. BENDL J, Hauberg ME, Girdhar K, Im E, et al
    The three-dimensional landscape of cortical chromatin accessibility in Alzheimer's disease.
    Nat Neurosci. 2022 Sep 28. pii: 10.1038/s41593-022-01166.
    PubMed         Abstract available
    
    

    
    Nature

33. PRILLAMAN M
    Alzheimer's drug slows mental decline in trial - but is it a breakthrough?
    Nature. 2022 Sep 29. pii: 10.1038/d41586-022-03081.
    PubMed        
    
    

    
    Neurobiol Aging

34. KOTLIAR K, Ortner M, Conradi A, Hacker P, et al
    Altered retinal cerebral vessel oscillation frequencies in Alzheimer's disease compatible with impaired amyloid clearance.
    Neurobiol Aging. 2022;120:117-127.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

35. KHANDELWAL M, Manglani K, Upadhyay P, Azad M, et al
    AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
    Neurobiol Dis. 2022;174:105876.
    PubMed         Abstract available
    
    
36. DE FISENNE MA, Yilmaz Z, De Decker R, Suain V, et al
    Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in mouse models.
    Neurobiol Dis. 2022 Sep 22:105875. doi: 10.1016/j.nbd.2022.105875.
    PubMed         Abstract available
    
    

    
    Neurology

37. BEVERSDORF DQ, Scharre DW
    The Dilemma of the Clinical Utility of Alzheimer Biomarker Evaluation in Everyday Clinical Practice: My Favorite PETs.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201478.
    PubMed        
    
    

    
    Neurosci Lett

38. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

39. HUANG Y, Rafael Guimaraes T, Todd N, Ferguson C, et al
    G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model.
    Proc Natl Acad Sci U S A. 2022;119:e2204828119.
    PubMed         Abstract available
    
    
40. TIAN J, Ren M, Zhao P, Luo S, et al
    Dissection of the long-range projections of specific neurons at the synaptic level in the whole mouse brain.
    Proc Natl Acad Sci U S A. 2022;119:e2202536119.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: